The Affymax management team has extensive experience in the biotechnology and pharmaceutical industries. Members of this proven team have been instrumental in the discovery, development and commercialization of more than 40 drugs in worldwide markets.
Executive Management
Arlene M. Morris
President and Chief Executive Officer
Paul B. Cleveland
Chief Financial Officer and Executive Vice President, Corporate Development
Anne-Marie Duliege, M.D., M.S.
Chief Medical Officer
Jeffrey H. Knapp
Chief Commercial Officer
Kay Slocum
Senior Vice President, Human Resources
Christine Conroy, Pharm.D.
Vice President, Regulatory Affairs and Good
Clinical Practice Compliance
Tracy J. Dunn, Ph.D., J.D.
Vice President, Intellectual Property and Legal Affairs
Carol Francisco, Ph.D.
Vice President, Biostatistics and Data Management
Steven Love
Vice President, Finance
Grace U. Shin, J.D.
General Counsel
Robert F. Venteicher, Ph.D.
Senior Vice President, Technical Operations
Arlene M. Morris
President and Chief Executive Officer
Ms. Morris has served as Affymax’s president and chief executive officer and as a member of the board of directors since 2003. From 2001 to 2003, Ms. Morris served as president and chief executive officer at Clearview Projects, an advisory firm to biopharmaceutical and biotechnology companies on strategic transactions. From 1996 to 2001, Ms. Morris served as senior vice president of Business Development at Coulter Pharmaceutical, Inc., a pharmaceutical company. From 1993 to 1996, Ms. Morris served as vice president of Business Development at Scios Inc., a biopharmaceutical company. From 1977 to 1993, Ms. Morris held positions of increasing responsibility at Johnson & Johnson, including vice president of Business Development for McNeil Pharmaceutical. Ms. Morris serves as a member of the board of directors of MediciNova, Inc., a biopharmaceutical company, and Phenomix Corporation, a biopharmaceutical company, and as a member of the board of directors of the Biotechnology Industry Organization. Ms. Morris holds a B.A. from Carlow College and has studied marketing at Western New England College.
Top
Paul B. Cleveland
Chief Financial Officer and Executive Vice President, Corporate Development
Mr. Cleveland has served as Affymax’s executive vice president, Corporate Development and chief financial officer since January 2006. From April 2004 to December 2005, Mr. Cleveland served as a managing director at Integrated Finance, Ltd., an investment bank. From September 1996 to April 2003, Mr. Cleveland served as a managing director at J.P. Morgan Chase and Co. (and a predecessor firm, Hambrecht & Quist), an investment bank. From January 1993 to September 1996, Mr. Cleveland was a partner at Cooley Godward LLP, a law firm. From December 1988 to December 1992, he was a corporate attorney at Sidley & Austin LLP, a law firm, and from September 1981 to November 1988, he was a corporate attorney at Davis Polk & Wardwell, a law firm. Mr. Cleveland serves as a member of the board of directors of Sangamo BioSciences, Inc., a biotechnology company. Mr. Cleveland holds a J.D. from Northwestern University School of Law and an A.B. from Washington University in St. Louis.
Top
Anne-Marie Duliege, M.D., M.S.
Chief Medical Officer
Dr. Duliege has served as Affymax’s chief medical officer since July 2007 and prior to that served as vice president, Clinical, Medical and Regulatory Affairs since 2004. Since 1998, Dr. Duliege has also practiced medicine at the Lucille Packard Children’s Hospital at Stanford University Medical Center. From 1992 to 2004, Dr. Duliege served in various positions at Chiron Corporation, a biotechnology company, most recently as senior medical director. Dr. Duliege holds an M.D. and M.S. from Paris Medical School and an M.S. from Harvard School of Public Health.
Top
Jeffrey H. Knapp
Chief Commercial Officer
Mr. Knapp has served as Affymax’s chief commercial officer since July 2006. From November 2005 to April 2006, Mr. Knapp served as senior vice president, Sales and Marketing at Abgenix, Inc., a biopharmaceutical company. From October 2004 to July 2005, Mr. Knapp served as vice president, Sales and Marketing, North America at Pharmion Corporation, a pharmaceutical company. From November 2001 to October 2004, Mr. Knapp served as vice president, U.S. sales and marketing at EMD Pharmaceuticals, a division of Merck KGaA, a pharmaceutical company. He has also held sales, marketing and business development positions at Eli Lilly and Company and ScheringPlough Corporation, both pharmaceutical companies. Mr. Knapp holds a B.A. from Wittenberg University.
Top
Kay Slocum
Senior Vice President, Human Resources
Ms. Slocum has served as Affymax’s senior vice president, Human Resources since June 2006. From 2003 to 2006, Ms. Slocum served as a human resources consultant to us. From 2001 to 2003, Ms. Slocum served as vice president, Human Resources of Deltagen, Inc., a biotechnology company. She also served as a vice president of Human Resources at Corixa Corporation (formerly Coulter Pharmaceutical), a biotechnology company. Earlier in her career, Ms. Slocum served as manager of Corporate Employee Development for Varian Associates and management consultant for Coulter Corporation, a biotechnology company. Ms. Slocum holds a B.A. from Southern Illinois University and an M.S. from Loyola University of Chicago.
Top
Christine Conroy, Pharm.D.
Vice President, Regulatory Affairs and Good Clinical Practice Compliance
Dr. Conroy has served as Affymax’s vice president, Regulatory Affairs and Good Clinical Practice Compliance since July 2007. From 2004 to 2006, Dr. Conroy served as Affymax’s senior director, Regulatory Affairs, and from 2006 to 2007 as executive director, Regulatory Affairs. From 2002 to 2004, Dr. Conroy served as senior director, Regulatory Affairs, for Genitope Corporation, a biotechnology company. From 1995 to 2001, Dr. Conroy held several positions at Roche Global Development, a pharmaceutical company, including regulatory program director with global responsibilities. From 1989 to 1994, Dr. Conroy held several positions at Syntex Laboratories, a pharmaceutical company including manager of Medical Services Department, Drug Information Service. From 1982 to 1989, Dr. Conroy served as staff pharmacist at St. Luke’s Hospital in Colorado. She holds a Pharm.D. from the University of Kansas, School of Pharmacy, and a B.S. in pharmacy from the University of Colorado, School of Pharmacy.
Top
Tracy J. Dunn, Ph.D., J.D.
Vice President, Intellectual Property and Legal Affairs
Dr. Dunn has served as Affymax’s vice president, Intellectual Property and Legal Affairs since 2002. From 1996 to 2002, Dr. Dunn served as director of Intellectual Property at Aviron, a biotechnology company, and subsequently at Medimmune Vaccines, Inc., a biotechnology company. From 1991 to 1996, Dr. Dunn was a patent attorney at Townsend and Townsend and Crew in Palo Alto, California. Dr. Dunn holds B.S., Ph.D. and J.D. degrees from the University of Wisconsin, where he also completed a National Cancer Institute post-doctoral research fellowship.
Top
Carol Francisco, Ph.D.
Vice President, Biostatistics and Data Management
Dr. Francisco joined as Affymax’s vice president, Biostatistics & Data Management in April 2008. Prior to joining the Company, Dr. Francisco was vice president of Biostatistics at ICON Clinical Research, Inc., a clinical research organization since 2000. From 1995 to 1999, Dr. Francisco held the position of vice president, Biostatistics and Data Management at Pacific Research Associates, Inc., a contracts services company. From 1994 to 1995, Dr. Francisco served as director, Biostatistics Department at Hoffman-La Roche, Inc., a pharmaceutical company. From 1986 to 1994, Dr. Francisco was department head, Biostatistics Department at Syntex Laboratories, Inc., a pharmaceutical company. Dr. Francisco holds a holds a Ph.D. in statistics from Iowa State University, a M.A. in psychology from Western Washington University and a B.A. from Western Washington State College.
Top
Steven Love
Vice President, Finance
Mr. Love has served as Affymax’s vice president, Finance since August 2007. From 2004 to 2007, Mr. Love served as vice president, Finance and Administration for Connetics Corporation, a specialty pharmaceutical company acquired by Stiefel Laboratories, Inc. in December 2006. From 2002 to 2004, Mr. Love served as vice president, Finance at Informatica Corporation, a software company. From 1999 to 2002, Mr. Love held positions of increasing responsibility at Portal Software, Inc., a software company, including senior director, Worldwide Sales Operations, and corporate controller. Mr. Love also served as a manager, Assurance and Advisory Business Services at Ernst & Young LLP, an independent registered public accounting firm. Mr. Love holds B.S. and M.A. degrees in accounting from the University of Southern California.
Top
Grace U. Shin, J.D.
General Counsel
Ms. Shin has served as Affymax’s general counsel since June 2008 and prior to that served as vice president, Legal Affairs and corporate counsel since October 2006. From May 1997 to April 2006, Ms. Shin served as corporate counsel to FibroGen, Inc., a biotechnology company, and since 2000 held the position of vice president of Legal Affairs and corporate counsel. From 1992 to 1997, Ms. Shin was a corporate attorney at Pacific Gas & Electric Company, a public utility. From to 1989 to 1992, Ms. Shin was a business associate at Cooley Godward LLP, a law firm. Ms. Shin holds a J.D. from the University of Michigan Law School and a B.A. from the University of Michigan School of Business Administration.
Top
Robert F. Venteicher, Ph.D.
Senior Vice President, Technical Operations
Dr. Venteicher has served as Affymax’s senior vice president, Technical Operations since June 2008 and prior to that served as vice president, Technical Operations since August 2007. From 1995 to 2007, Dr. Venteicher held several positions at Elan Pharmaceuticals, Inc., a pharmaceutical company, most recently as vice president, R&D Quality and Compliance. From 1992 to 1995, Dr. Venteicher held several positions at Univax Biologics, Inc., a pharmaceutical company, including vice president, Quality Assurance/Quality Control. From 1988 to 1992, Dr. Venteicher was head, R&D Pharmaceutical Quality Control and associate director of Bioprocess and Analytical Development at Centocor Inc., a biotechnology company. Dr. Venteicher also held scientific and management positions with increasing responsibilities during his 10-year tenure at Hoffmann LaRoche, Inc., a pharmaceutical company. Dr. Venteicher holds a Ph.D. in chemistry from Pennsylvania State University and a B.S. in chemistry from Iowa State University. Dr. Venteicher completed postdoctoral training in biochemistry and biophysics at Johnson Research Foundation, University of Pennsylvania.
Top
|
